Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics
Evaluation of the Antimicrobial Activity In Vitro of Tigecycline in Comparison to Other Broad Spectrum Antibiotics in Isolates Collected From Patients
Various bacterial organisms will be tested in order to compile information regarding the effectiveness of tigecycline against certain bacteria seen in local communities.
This is a prospective, microbiologic in vitro evaluation which will study the susceptibility of tigecycline in disk diffusion on clinical bacterial isolates collected from inpatients and outpatients. Fourteen hospital centers participated in the program. In vitro efficacy of tigecycline will be determined through the in vitro disk diffusion activity, using FDA breakpoints.
Time Perspective: Prospective
Target Follow-Up Duration
Hospitalized patients and outpatients
A listing of all isolates meeting the inclusion criteria will be maintained.
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Actual Enrollment (submitted: March 7, 2011)
Original Actual Enrollment
Same as current
Actual Study Completion Date
Primary Completion Date
Inclusion Criteria: Any protocol-specified microorganism isolated from the samples collected from hospitalized patients and outpatients
Sexes Eligible for Study:
Child, Adult, Older Adult
Accepts Healthy Volunteers
Contact information is only displayed when the study is recruiting subjects